Alliance sources Sytrinol
exclusive worldwide distribution rights for the
cholesterol-lowering product Sytrinol.
SourceOne Global is to distribute the citrus-based cholesterol-lowering product Sytrinol, the first KGK Synergize product to gain patent protection.
Sytrinol is composed of polymethoxylated flavones and tocotrienols, which has been shown in multiple clinical trials to reduce total cholesterol 23 per cent, LDL cholesterol by 21 per cent and triglycerides 26 per cent, according to a joint statement by the companies. They add that Sytrinol is not diet specific and has no known side effects.
Najla Guthrie, president and CEO of KGK Synergize, commented: "Sytrinol is KGK's first patented product to come to market and I am very confident in SourceOne's ability to bring Sytrinol to its full market potential."
Jesse Lopez, president of SourceOne Global, added: "Our company is built on the concept of sourcing and delivering safe, efficacious, science-based products. I'm confident this is just the first of many successful product launches with our new partner."
For additional information on Sytrinol contact Tiia Sumera.
